{
  "id": 5661571,
  "title": "Ceribell CEO Chao Xingjuan sells $973,079 in company stock",
  "url": "https://urgent.news/2026/09/04/ceribell-ceo-chao-xingjuan-sells-973-079-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-04T22:46:04.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/ceribell-ceo-chao-xingjuan-sells-973079-in-company-stock-93CH-4890095"
  },
  "original_language": "en",
  "account": "Ceribell's CEO, Chao Xingjuan, recently sold 39,540 shares of the company's common stock for around $973,079 on September 2, 2026. The transactions occurred near the stock's 52-week high of $25.33, following a 100% gain over the past year, bringing the market capitalization to $943 million. Simultaneously, Xingjuan acquired 25,000 shares through stock options, exercising them at $4.70 per share, totaling about $117,500. These actions were part of a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2025. As a result, Xingjuan now directly owns 767,191 shares of Ceribell common stock. She also indirectly owns 369,088 shares through the ACP 2021 Trust, where she serves as a co-trustee, except for her pecuniary interest. Ceribell reported a 33% increase in second-quarter revenue to $28.1 million for fiscal 2026, despite posting a loss of $0.51 per share. Analysts like Canaccord and Raymond James have raised their price targets for Ceribell shares, citing growth drivers such as its expansion in seizure-detection business and pediatric care products.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}